Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Restoring hair follicle immune privilege may help treat alopecia areata.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

The model helps understand scar contraction and develop new treatments.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

The spiny mouse regenerates ear tissue asymmetrically, with gene expression differences possibly explaining its unique healing abilities.

PRP is effective for treating patchy alopecia areata.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.